Evaluating susceptibility to pancreatic cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works

Very high risk of cancer in familial Peutz–Jeghers syndrome

Giardiello, F. M., Brensinger, J. D., Tersmette, A. C., Goodman, S. N., Petersen, G. M., Booker, S. V., Cruz–Correa, M., & Offerhaus, G. J. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.20228 · Cited by 1,435 · see citing works

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 939 · see citing works

International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

Canto, M. I., Harinck, F., Hruban, R. H., Offerhaus, G. J., Poley, J.-W., Kamel, I., Nio, Y., Schulick, R. S., Bassi, C., Kluijt, I., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303108 · Cited by 784 · see citing works

Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer

Hu, C., Hart, S. N., Polley, E. C., Gnanaolivu, R., Shimelis, H., Lee, K. Y., Lilyquist, J., Na, J., Moore, R., Antwi, S. O., et al. (2018) · JAMA · doi:10.1001/jama.2018.6228 · Cited by 577 · see citing works

Risk of Pancreatic Cancer in Families With Lynch Syndrome

Kastrinos, F. (2009) · JAMA · doi:10.1001/jama.2009.1529 · Cited by 544 · see citing works

Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance

Canto, M. I., Almario, J. A., Schulick, R. D., Yeo, C. J., Klein, A., Blackford, A., Shin, E. J., Sanyal, A., Yenokyan, G., Lennon, A. M., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.035 · Cited by 414 · see citing works

Germline <i>BRCA</i> Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma

Holter, S., Borgida, A., Dodd, A., Grant, R., Semotiuk, K., Hedley, D., Dhani, N., Narod, S., Akbari, M., Moore, M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7401 · Cited by 398 · see citing works

American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers

Lu, K. H., Wood, M. E., Daniels, M. S., Burke, C., Ford, J. M., Kauff, N. D., Kohlmann, W. K., Lindor, N. M., Mulvey, T. M., Robinson, L. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9257 · Cited by 238 · see citing works

Screening for pancreatic cancer in familial high-risk individuals: A systematic review

Lu, C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i28.8678 · Cited by 85 · see citing works

Refinement of screening for familial pancreatic cancer

Bartsch, D. K., Slater, E. P., Carrato, A., Ibrahim, I. S., Guillen-Ponce, C., Vasen, H. F. A., Matthäi, E., Earl, J., Jendryschek, F. S., Figiel, J., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311098 · Cited by 85 · see citing works

Lost in translation: returning germline genetic results in genome-scale cancer research

Initiative, A. P. C. G., Johns, A. L., McKay, S. H., Humphris, J. L., Pinese, M., Chantrill, L. A., Mead, R. S., Tucker, K., Andrews, L., Goodwin, A., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0430-4 · Cited by 79 · see citing works

<i>BRCA1</i> and <i>BRCA2</i> germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts

Lucas, A. L., Frado, L. E., Hwang, C., Kumar, S., Khanna, L. G., Levinson, E. J., Chabot, J. A., Chung, W. K., & Frucht, H. (2014) · Cancer · doi:10.1002/cncr.28662 · Cited by 68 · see citing works

Screening in GI Cancers: The Role of Genetics

Stoffel, E. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.6764 · Cited by 30 · see citing works

High-risk population in sporadic pancreatic adenocarcinoma: guidelines for screening

Bruenderman, E. H., & Martin, R. C. G. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.06.046 · Cited by 28 · see citing works

The Immune Microenvironment in Pancreatic Cancer

Huber, M., Brehm, C. U., Gress, T. M., Buchholz, M., Alhamwe, B. A., von Strandmann, E. P., Slater, E. P., Bartsch, J. W., Bauer, C. A., & Lauth, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197307 · Cited by 243 · see citing works

Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation

Wattenberg, M. M., Asch, D., Yu, S., O'Dwyer, P. J., Domchek, S. M., Nathanson, K. L., Rosen, M. A., Beatty, G. L., Siegelman, E. S., & Reiss, K. A. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0582-7 · Cited by 206 · see citing works

Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review

Kenner, B., Chari, S. T., Kelsen, D., Klimstra, D. S., Pandol, S. J., Rosenthal, M., Rustgi, A. K., Taylor, J. A., Yala, A., Abul-Husn, N., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001762 · Cited by 158 · see citing works

Cancer Genetic Counseling—Current Practice and Future ChallengesPreprint

Schienda, J., & Stopfer, J. E. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036541 · Cited by 54 · see citing works

Familial Pancreatic Cancer: Current Perspectives

Llach, J., Carballal, S., & Moreira, L. (2020) · Cancer Management and Research · doi:10.2147/cmar.s172421 · Cited by 48 · see citing works

Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer

Zhang, J., Wang, Y., Zhao, T., Li, Y., Tian, L., Zhao, J., & Zhang, J. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-1809-z · Cited by 41 · see citing works

Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer

Lorenzo, D., Rebours, V., Maire, F., Palazzo, M., Gonzalez, J., Vullierme, M., Aubert, A., Hammel, P. R., Lévy, P., & de Mestier, L. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i34.5082 · Cited by 25 · see citing works

Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients

Puccini, A., Ponzano, M., Dalmasso, B., Vanni, I., Gandini, A., Puglisi, S., Borea, R., Cremante, M., Bruno, W., Andreotti, V., et al. (2022) · Cancers · doi:10.3390/cancers14184447 · Cited by 21 · see citing works

Genetic Counseling for Hereditary Gastric and Pancreatic Cancer in High-Risk Gastrointestinal Cancer Clinics: An Effective Strategy

Llach, J., Moreno, L., Sánchez, A., Herrera‐Pariente, C., Ocaña, T., Cuatrecasas, M., Rivero, L., Moreira, R., Díaz, M., Jung, G., et al. (2020) · Cancers · doi:10.3390/cancers12092386 · Cited by 11 · see citing works

Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma

Cremin, C., Bedard, A. C., Hong, Q., Mung, S. W., Nuk, J., Wong, A., Akbar, H., Cheung, E., Renouf, D. J., Schaeffer, D., et al. (2024) · JCO Precision Oncology · doi:10.1200/po.24.00167 · Cited by 8 · see citing works

Early features of pancreatic cancer on magnetic resonance imaging (MRI): a case–control study

Parker, R. A., Zhou, Y., Puttock, E. J., Chen, W., Lustigova, E., & Wu, B. U. (2024) · Abdominal Radiology · doi:10.1007/s00261-024-04271-2 · Cited by 7 · see citing works

Descriptive, analytical and molecular epidemiology of pancreatic cancer

Shangina, O., Maximovich, D. M., & Zaridze, D. G. (2022) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2022-21-3-90-103 · Cited by 6 · see citing works

Examination of ATM, BRCA1, and BRCA2 promoter methylation in patients with pancreatic cancer

Zhou, C., Porter, N. R., Borges, M. W., Gauthier, C. D., Ferguson, L. G., Huang, B., Nanda, N., He, J. P., Laheru, D. A., Hruban, R. H., et al. (2021) · Pancreatology · doi:10.1016/j.pan.2021.03.015 · Cited by 5 · see citing works

Pancreatic cancer risk to siblings of probands in bilineal cancer settings

Rabe, K. G., Stevens, M. A., Hernández, A. T., Chandra, S., Hubbard, J. M., Kemppainen, J. L., Majumder, S., & Petersen, G. M. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.01.016 · Cited by 5 · see citing works

Understanding familial risk of pancreatic ductal adenocarcinoma

Paranal, R. M., Wood, L. D., Klein, A. P., & Roberts, N. J. (2024) · Familial Cancer · doi:10.1007/s10689-024-00383-2 · Cited by 4 · see citing works

Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology Clinic

Sinan, H., Cunningham, D., Sleiman, E. A., Petry, D., McPhaul, T. J., Visvanathan, K., Armstrong, D. K., He, J. P., Burkhart, R. A., Pishvaian, M. J., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-24-00494 · Cited by 4 · see citing works

Should We Offer Universal Germline Genetic Testing to All Patients with Pancreatic Cancer? A Multicenter Study

Llach, J., Luzko, I., Earl, J., Barreto, E., Rodríguez-Garrote, M., Lleixà, M., Herrera‐Pariente, C., Fernández, G., Muñoz, J., Bonjoch, L., et al. (2024) · Cancers · doi:10.3390/cancers16223779 · Cited by 3 · see citing works

Pancreatic Cancer Screening among High-risk Individuals

Turner, K. M., & Patel, S. H. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.03.002 · Cited by 3 · see citing works

Role of Endoscopic Ultrasound in Pancreatic Cancer Screening

Cannizzaro, R., Magris, R., Maiero, S., Guarnieri, G., Fornasarig, M., & Canzonieri, V. (2021) · Springer eBooks · doi:10.1007/978-3-030-71937-1_11

Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma

Lew, D., & Kwok, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_29-1

Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma

Lew, D., & Kwok, K. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_29

Étude de la tumorigenèse pancréatique des tumeurs intracanalaires papillaires et mucineuses du pancréas (TIPMP)

Lorenzo, D. (2024) · doi:10.70675/ba1107b2ze1c9z4e6ezad24z3a1778a18d7e

Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary

Khorana, A. A., Mangu, P. B., & Katz, M. H. G. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2017.023044 · Cited by 25 · see citing works

Pancreatic AdenocarcinomaPractice Guidelines in Oncology

Warren, R. S., Whiting, S. H., Willett, C. G., Wolff, R. A., Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben‐Josef, E., Benson, A. B., Berlin, J. D., et al. (2010) · Cited by 1 · see citing works

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion

Stoffel, E. M., McKernin, S. E., Brand, R. E., Canto, M. I., Goggins, M., Moravek, C., Nagarajan, A., Petersen, G. M., Simeone, D. M., Yurgelun, M. B. B., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.01489 · Cited by 205 · see citing works

ASO Visual Abstract: Resected Early-Onset Pancreatic Cancer—Practices and Outcomes in an International Dual-Center Study

Leonhardt, C.-S., Kinny‐Köster, B., Hank, T. P., Habib, J. R., Shoucair, S., Klaiber, U., Cameron, J. L., Hackert, T., Wolfgang, C. L., Büchler, M. W., et al. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-022-13037-3

ASO Visual Abstract: Adjuvant Therapy After Upfront Resection of Resectable Pancreatic Cancer: Patterns of Omission and Use—A Prospective Real-Life Study

Paiella, S., Malleo, G., Lionetto, G., Cattelani, A., Casciani, F., Secchettin, E., Pastena, M. D., Bassi, C., & Salvia, R. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-15024-2